Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis
- PMID: 37446943
- PMCID: PMC10343386
- DOI: 10.3390/molecules28135283
Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis
Abstract
Early detection is crucial for the treatment and prognosis of oral cancer, a potentially lethal condition. Tumor markers are abnormal biological byproducts produced by malignant cells that may be found and analyzed in a variety of bodily fluids, including saliva. Early detection and appropriate treatment can increase cure rates to 80-90% and considerably improve quality of life by reducing the need for costly, incapacitating medicines. Salivary diagnostics has drawn the interest of many researchers and has been proven to be an effective tool for both medication monitoring and the diagnosis of several systemic diseases. Since researchers are now searching for biomarkers in saliva, an accessible bodily fluid, for noninvasive diagnosis of oral cancer, measuring tumor markers in saliva is an interesting alternative to blood testing for early identification, post-treatment monitoring, and monitoring high-risk lesions. New molecular markers for oral cancer detection, treatment, and prognosis have been found as a result of developments in the fields of molecular biology and salivary proteomics. The numerous salivary tumor biomarkers and how they relate to oral cancer and pre-cancer are covered in this article. We are optimistic that salivary protein biomarkers may one day be discovered for the clinical detection of oral cancer because of the rapid advancement of proteomic technology.
Keywords: early detection; oral cancer; protein biomarkers; saliva; salivary proteomic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Shaping the future of oral cancer diagnosis: advances in salivary proteomics.Expert Rev Proteomics. 2024 Apr;21(4):149-168. doi: 10.1080/14789450.2024.2343585. Epub 2024 Apr 24. Expert Rev Proteomics. 2024. PMID: 38626289 Review.
-
A Review on Salivary Proteomics for Oral Cancer Screening.Curr Issues Mol Biol. 2020;37:47-56. doi: 10.21775/cimb.037.047. Epub 2020 Jan 17. Curr Issues Mol Biol. 2020. PMID: 31950916 Review.
-
Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.J Proteomics. 2020 Feb 10;212:103574. doi: 10.1016/j.jprot.2019.103574. Epub 2019 Nov 7. J Proteomics. 2020. PMID: 31706945
-
Role of Salivary Biomarkers in Oral Cancer Detection.Adv Clin Chem. 2018;86:23-70. doi: 10.1016/bs.acc.2018.05.002. Epub 2018 Jul 23. Adv Clin Chem. 2018. PMID: 30144841 Review.
-
Salivary biomarkers for oral cancer and pre-cancer screening: a review.Clin Oral Investig. 2018 Mar;22(2):633-640. doi: 10.1007/s00784-018-2337-x. Epub 2018 Jan 17. Clin Oral Investig. 2018. PMID: 29344805 Review.
References
-
- Chaubron F. Method of Evaluating Cancer Risk in Human (EP) No. 8,993,333. U.S. Patent. 2015 March 31;
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical